Only 29% of the subjects with positive AD biomarker profile had normal NFL levels, suggesting that a pure AD biochemical profile without signs of NFL leakage is unusual in subjects undergoing testing for dementia biomarkers. The gene discussed is NEFL; the disease is dementia.